ACM Research, Inc. ACMR ← Back to all reports

ACM Research, Inc.

ACMR · Technology
B ★★★ Hold
Aug 17, 2026 · Score 76 · Type B — Growth-style analysis Used for higher-growth companies — weighs revenue trajectory, total addressable market (TAM) expansion, and forward-looking multiples. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $80.42
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $70.00 ($65.00–$75.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $115.12
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+43.1%

Type B - ACM Research, Inc. (ACMR) 20260817 Stock Analysis

📅 ACM Research Key Upcoming Events

🏢 Step 1: ACM Research Company Overview & Business Model

Q1-A1. What is ACM Research?

Q1-A2. How Does ACM Research Make Money?

Q1-A3. ACM Research’s Revenue Segments & Core Income Sources

Q1-A4. Who Are ACM Research’s Competitors?

Q1-A5. What Problem Does ACM Research Solve?

Q1-A6. ACM Research Key Milestones: Past 12 Months

Q1-A7. Step 1 Key Takeaways

🌲 Step 2: ACM Research’s Economic Moat, Market Size & Scalability

Q2-A1. Does ACM Research Have a Durable Economic Moat?

Q2-A2. How Big Is ACM Research’s Market? (TAM)

Q2-A3. How Real Is ACM Research’s TAM? (Quality Check)

Q2-A4. Can ACM Research Keep Expanding Its Market?

Q2-A5. Step 2 Key Takeaways

🚀 Step 3: How Fast Is ACM Research Growing? Hyper-Growth Metrics

Q3-A1. How Fast Is ACM Research Growing? (Revenue Trajectory)

Q3-A2. ACM Research’s Key Growth Metrics

Q3-A3. Are ACM Research’s Unit Economics Improving?

Q3-A4. Step 3 Key Takeaways

💪 Step 4: ACM Research’s Profit Potential & Free Cash Flow

Q4-A1. Can ACM Research Turn Growth Into Profit?

Q4-A2. Does ACM Research Generate Free Cash Flow?

Q4-A3. Step 4 Key Takeaways

👔 Step 5: ACM Research Management & Shareholder Alignment

Q5-A1. Who Leads ACM Research? (Founder & Management)

Q5-A2. Is ACM Research’s Management Aligned With Shareholders?

Q5-A3. Step 5 Key Takeaways

⛵ Step 6: ACM Research Market Flow & Sentiment

Q6-A1. Analyst Consensus vs ACM Research Guidance

Q6-A2. What Is ACM Research’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🧨 Step 7: ACM Research Catalysts & Price Triggers

Q7-A1. What Could Re-Rate ACM Research Stock? (Next 12 Months)

Q7-A2. ACM Research’s Estimate Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is ACM Research Fairly Valued? Valuation Analysis

Q8-A1. ACM Research’s Key Valuation Multiples

Q8-A2. ACM Research vs Peers: Valuation Comparison

Q8-A3. What Is ACM Research Worth in the Future? (Forward Valuation)

Q8-A3-1. What Growth Hurdle Does the Market Demand From ACM Research? (Forward Valuation Alternative)

Q8-A4. Final Valuation Adjustment

Q8-A5. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of ACM Research? Fatal Risks & Pre-Mortem

Q9-A1. Is ACM Research Burning Cash & Diluting Shareholders?

Q9-A2. Do Competition or Regulation Threaten ACM Research?

Q9-A3. ACM Research Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: ACM Research Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy ACM Research? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. ACM Research’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is ACM Research’s Extreme Geographic Concentration in Mainland China Its Biggest Weakness?

Q2: Can ACM Research’s High Forward P/E Be Justified by the Chinese Fab Localization Supercycle?

Q3: Will the 2024 BIS Entity List Inclusion of ACM Shanghai Ultimately Strangle Long-Term Supply Chains?

Q4: Can the Ultra ECP ap-p Panel-Level Packaging Tool Drive the Next Leg of Structural Growth?

Q5: Is the Severe Negative Free Cash Flow a Structural Flaw or a Calculated Growth Investment?

Q6: How Secure is the 46.0% Gross Margin Against the Scaling of New Product Platforms?

Q7: Does the Heavy Insider Selling by CEO David Wang Signal a Looming Cyclical Peak?

Q8: Can the “Fast Follower” Strategy in Furnace and PECVD Succeed Against Global Incumbents?

Q9: What is the Fundamental Impact of Operating in a Sanction-Driven Captive Market?

Q10: Is the 105% First-Half Order Surge Sustainable Demand or Panic-Hoarding?